Airsculpt Technologies, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
AIRS$0.77+14.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| ($000s) | 2025 | 2024 | 2023 |
| Cash flows from operating activities | |||
| Net loss | $(11,667) | $(8,018) | $(4,240) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 12,781 | 11,888 | 10,253 |
| Equity-based compensation | 2,331 | 3,762 | 18,224 |
| Non-cash interest expense; amortization of debt costs | 525 | 339 | 207 |
| Deferred income taxes | (5,914) | (252) | 1,342 |
| Loss on impairment of long-lived assets | 4,575 | 16 | (212) |
| Cost related to closing location | 2,152 | — | — |
| Changes in assets and liabilities | |||
| Taxes receivable | 1,556 | (1,115) | 890 |
| Prepaid expense and other current assets | (4,440) | (2,059) | 466 |
| Other assets | 6,669 | (2,882) | (4,711) |
| Accounts payable | 579 | 739 | (206) |
| Deferred revenue and patient deposits | 735 | (293) | (896) |
| Accrued and other liabilities | (6,786) | 9,225 | 2,839 |
| Net cash used in operating activities | 3,096 | 11,350 | 23,956 |
| Cash flows from investing activities | |||
| Purchases of property and equipment, net | (2,404) | (14,007) | (9,919) |
| Net cash used in investing activities | (2,404) | (14,007) | (9,919) |
| Cash flows from financing activities | |||
| Payments on term loan | (13,793) | (2,125) | (12,125) |
| Payments for debt modification | (393) | (136) | — |
| Payments on revolving credit facility | (5,000) | 5,000 | — |
| Proceeds from public offerings, net | 18,764 | — | — |
| Distribution to member | — | — | (79) |
| Dividends paid to shareholders | — | (252) | (385) |
| Payment of taxes withheld through vested equity-based compensation | (56) | (903) | (233) |
| Other financing activity | — | (954) | (569) |
| Net cash used in financing activities | (478) | 630 | (13,391) |
| Net decrease in cash and cash equivalents | 214 | (2,027) | 646 |
| Cash and cash equivalents | |||
| Beginning of period | 8,235 | 10,262 | 9,616 |
| End of period | $8,449 | $8,235 | $10,262 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | $5,562 | $5,997 | $6,277 |
| Supplemental disclosure of non-cash investing information: | |||
| Property and equipment included in accounts payable and accrued expenses | $1,578 | $1,595 | $283 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.